Key result
Microvolt T-wave alternans (MTWA) is evaluated as a risk stratification tool for predicting sudden cardiac death and guiding implantable cardioverter-defibrillator selection in chronic heart failure.
Why the study?
Does microvolt T-wave alternans predict sudden cardiac death in patients with chronic heart failure?
Does microvolt T-wave alternans predict sudden cardiac death in patients with chronic heart failure?
Answers are grounded in this paper and cite their sources.
This review evaluates the utility of microvolt T-wave alternans for risk stratifying patients with chronic heart failure to guide ICD implantation for the prevention of sudden cardiac death.
Despite recent advances in the prevention and treatmentof cardiovascular disease, sudden cardiac death (SCD) still accounts for 50 % of all cardiovascular deaths in developed countries, thus accounting for a significant propor-tion of annual death worldwide.1 Reduction of the incidence of SCD depends on identification of those at most risk. In the present review we will concentrate on the challenges of risk stratification for SCD in chronic heart failure (CHF). We evaluate the utility of microvolt T-wave alternans (MTWA) as a tool for predicting SCD and consider whether MTWA is currently a valid means of selecting which patients should, or should not, receive an implantable cardioverter-defibrillator (ICD). Prevention of Sudden Cardiac Death Until recently, attempts to prevent SCD relied on pharmaco-logical therapy. -Blockers,2 angiotensin-converting enzyme
No takes yet. Share an insight, caveat, or question.
Myles et al. (2007) conducted a review in Chronic heart failure. Microvolt T-wave alternans (MTWA) was evaluated on Sudden cardiac death. Microvolt T-wave alternans (MTWA) is evaluated as a risk stratification tool for predicting sudden cardiac death and guiding implantable cardioverter-defibrillator selection in chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: